MAPK3 and major depressive disorder: Increasing evidence supports a pivotal role of the ERK subclass of mitogen-activated protein kinase (MAPK), especially ERK1/2, which has been most thoroughly investigated and characterized in the PFC and hippocampus of depressed animals and has played a pivotal role in various neuropsychiatric disorders, including MDD [50–52].